Navigation Links
Poniard to Present Clinical Data From Picoplatin Trials in Multiple Tumor Types at American Society of Clinical Oncology 2008 Annual Meeting
Date:5/15/2008

harmaceutical company focused on the development and commercialization of innovative oncology products to impact the lives of people with cancer. For additional information please visit http://www.poniard.com.

This release contains forward-looking statements, including statements regarding the Company's business objectives and strategic goals, drug development plans, results of clinical trials and the potential safety and efficacy of its products in development. The Company's actual results may differ materially from those indicated in these forward-looking statements based on a number of factors, including risks and uncertainties associated with the Company's research and development activities; the results of pre-clinical and clinical testing; the receipt and timing of required regulatory approvals; the market's acceptance of the Company's proposed products; the Company's anticipated operating losses, need for future capital and ability to obtain future funding; competition from third parties; the Company's ability to preserve and protect intellectual property rights; the Company's dependence on third-party manufacturers and suppliers; the Company's lack of sales and marketing experience; the Company's ability to attract and retain key personnel; changes in technology, government regulation and general market conditions; and the risks and uncertainties described in the Company's current and periodic reports filed with the Securities and Exchange Commission (SEC), including the Company's Annual Report on Form 10-K for the year ended December 31, 2007 and Quarterly Report on Form 10-Q for the quarter ended March 31, 2008. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this release. The Company undertakes no obligation to update any forward-looking statement to reflect new information, events or circumstances after the date of this rele
'/>"/>

SOURCE Poniard Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Poniard Pharmaceuticals Licenses Kinase Inhibitors From The Scripps Research Institute
2. Poniard Pharmaceuticals Completes Enrollment of Phase 2 Picoplatin Trial in Colorectal Cancer
3. Poniard Pharmaceuticals Announces Final Picoplatin Data from Phase 2 Small Cell Lung Cancer Trial Demonstrating Survival Benefit
4. Poniard Pharmaceuticals Oral Picoplatin Demonstrates Positive Bioavailability in Ongoing Phase 1 Trial
5. Poniard Pharmaceuticals Announces Presentation of Clinical Data From Picoplatin Phase 2 Small Cell Lung Cancer Trial to be Presented at 1st IASLC-ESMO European Lung Cancer Conference
6. Poniard Pharmaceuticals Announces Commercial Manufacturing Agreement With W. C. Heraeus GmbH for Picoplatin
7. Poniard Pharmaceuticals Announces Clinical Data From Picoplatin Oral Phase 1 to Be Presented at the American Association of Cancer Research Annual Meeting
8. Poniard Pharmaceuticals Announces Positive First-line Phase 1 Safety and Efficacy Data With Picoplatin in Metastatic Prostate Cancer Patients
9. Poniard Pharmaceuticals Announces Picoplatin Safety Data in Colorectal Cancer
10. Poniard Pharmaceuticals Provides Year-End Clinical Update at 2007 Lazard Capital Markets Healthcare Conference
11. Poniard Pharmaceuticals Initiates Randomized Phase 2 Trial of Picoplatin for First-Line Treatment of Metastatic Colorectal Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... , March 27, 2015  Holographic Optical Technologies of ... field of holographic medical imaging, is entering the world ... campaign. Launching on April 20 th , 2015, the ... Pro. The 8-inch and 22-inch displays will allow consumers ... the first time. In addition to the two displays, ...
(Date:3/27/2015)... YORK , March 27, 2015 A new ... Latin America – Chile ... are top targets for IVD firms.  The healthcare ... figures heavily into IVD strategies for the Latin American continent ... to support globally distributed supply operations. However, the country,s regional ...
(Date:3/27/2015)... LONDON , March 27, 2015 ... commercial prospects for leading ophthalmic drug companies  ... the pharma ophthalmic industry ? Visiongain,s brand new ... trends, opportunities and prospects there. Our 242-page ... most lucrative areas in the industry and the future ...
Breaking Medicine Technology:Holographic Optical Technologies brings cutting-edge holograms to consumer market through upcoming Kickstarter campaign 2Holographic Optical Technologies brings cutting-edge holograms to consumer market through upcoming Kickstarter campaign 3Kalorama: Beyond Brazil, Latin American IVD Market Grows 2Kalorama: Beyond Brazil, Latin American IVD Market Grows 3Kalorama: Beyond Brazil, Latin American IVD Market Grows 4Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 2Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 3Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 4Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 5Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 6Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 7
... 30 Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) ... supporting the safety and efficacy of Caldolor® ( ibuprofen ) ... which was published in the August edition of the peer-reviewed ... decreased pain and morphine use when compared with placebo. ...
... LOUIS, Aug. 30 Recession-driven budget cuts by hospitals and ... AHPI ) throughout fiscal 2010.  The company managed ... overhead and operating costs.  Still, the company reported a loss ... ending June 30, 2010, Allied sales fell about $6 million, ...
Cached Medicine Technology:Pre and Post-Operative Use of Caldolor® (Ibuprofen) Injection Significantly Reduces Pain and Opioid Use in Newly Published Study 2Pre and Post-Operative Use of Caldolor® (Ibuprofen) Injection Significantly Reduces Pain and Opioid Use in Newly Published Study 3Pre and Post-Operative Use of Caldolor® (Ibuprofen) Injection Significantly Reduces Pain and Opioid Use in Newly Published Study 4Pre and Post-Operative Use of Caldolor® (Ibuprofen) Injection Significantly Reduces Pain and Opioid Use in Newly Published Study 5Recession Leads to Sales Decline and Loss for Allied Healthcare Products in Fiscal 2010 2Recession Leads to Sales Decline and Loss for Allied Healthcare Products in Fiscal 2010 3Recession Leads to Sales Decline and Loss for Allied Healthcare Products in Fiscal 2010 4Recession Leads to Sales Decline and Loss for Allied Healthcare Products in Fiscal 2010 5
(Date:3/29/2015)... 29, 2015 The Claudia Cohen ... Cancer announce today that Dr. Beth Y. Karlan ... Claudia Cohen Research Foundation Prize for Outstanding Gynecologic Researcher. ... of Gynecologic Oncology 46th Annual Meeting on Women's Cancer ... Cedars-Sinai Women’s Cancer Program at the Samuel Oschin Comprehensive ...
(Date:3/29/2015)... Youth Villages will participate in a partnership ... the feasibility of implementing a Pay for Success model ... their families. , Third Sector Capital Partners Inc. ran ... provided technical assistance throughout 2015 toward a Pay for ... awardees chosen by Third Sector. The organization’s work with ...
(Date:3/28/2015)... Rocket Pure , a manufacturer of natural body care ... natural sunscreen. They are offering the sunscreen in both ... with a bonus lip balm sunscreen. , The new products ... Click to see the natural sunscreen on Amazon . , ... with non-nano zinc oxide and provides broad-based protection against UVA ...
(Date:3/28/2015)... a bite of warm, gooey pepperoni pizza, and your ... stomach, ready to break down your meal. In many ... amok, triggering a burning sensation in the chest. Heartburn ... Americans have heartburn at least once a month. The ... can be stopped. , Heartburn or acid reflux symptoms ...
(Date:3/28/2015)... Emergency Medical Care (EMC), a New ... recently commemorated its three-year anniversary of being the only ... to 24-hour urgent care, Emergency Medical Care offers its ... time, Emergency Medical Care’s Urgent Care NYC ... eye injuries, ear infections, fevers, insect bites, burns, animal ...
Breaking Medicine News(10 mins):Health News:Dr. Beth Y. Karlan Named Recipient of the Claudia Cohen Research Foundation Prize for Outstanding Gynecologic Cancer Researcher 2015 2Health News:Dr. Beth Y. Karlan Named Recipient of the Claudia Cohen Research Foundation Prize for Outstanding Gynecologic Cancer Researcher 2015 3Health News:Dr. Beth Y. Karlan Named Recipient of the Claudia Cohen Research Foundation Prize for Outstanding Gynecologic Cancer Researcher 2015 4Health News:Youth Villages Partners with Two Oregon Counties to Advance Pay-for-Success Model to Help At-Risk Youth 2Health News:Youth Villages Partners with Two Oregon Counties to Advance Pay-for-Success Model to Help At-Risk Youth 3Health News:Youth Villages Partners with Two Oregon Counties to Advance Pay-for-Success Model to Help At-Risk Youth 4Health News:Rocket Pure Releases New Natural Sunscreens For Athletes 2Health News:Rocket Pure Releases New Natural Sunscreens For Athletes 3Health News:Bypass Your Heartburn Worries This Easter With Tylers Coffee 2Health News:Emergency Medical Care Celebrates Three Years of 24/7 Walk-In Urgent Care Services 2
... & Lomb withdrew its ReNu with MoistureLoc contact lens ... associated with it. Now in a new study ... these infections were fueled and made resistant to treatment ... microbial cells held together with a glue-like matrix material. ...
... physicians to help to identify over 25 common but overlooked diseases ... ... AUSTIN, Texas, Jan. 28 Biophysical Corporation,announced today the availability of ... some common medical,conditions, including heart disease and cancer, that are usually ...
... Encourages Americans to Help Kids Receive Care, CHICAGO, ... Month this February, the Wm. Wrigley Jr. Company,(NYSE: ... February gross sales in,the U.S. (up to another $100,000) ... A Smile(R), an annual American Dental,Association (ADA) program that ...
... News Service Weekly PressPac with news from ACS 36 peer-reviewed ... or the American Chemical Society as the source for this ... #5, which is embargoed for 9 A. M., Eastern Time, ... , Genetic telepathy? A bizarre new property ...
... of 4 cups a day led to spikes in blood ... research suggests the caffeine in those daily cups of java ... small group of 10 diabetics, glucose levels rose by 8 ... caffeine found in four cups of coffee. , "There,s reason ...
... 28 NutraCea (OTC Bulletin,Board: NTRZ), a world leader ... provided an update on its domestic,operations., The Company ... has been running at full capacity since the middle ... except when it is disassembled for,cleaning. Further, the facility ...
Cached Medicine News:Health News:New study finds resistant organisms at core of soft contact lens corneal infections 2Health News:Biophysical Unveils BiophysicalCheck Health Assessment Program to Aid in Pre-Symptomatic Detection of Disease 2Health News:Biophysical Unveils BiophysicalCheck Health Assessment Program to Aid in Pre-Symptomatic Detection of Disease 3Health News:Wrigley Keeps Kids Smiling Through Donation to American Dental Association Program 2Health News:Wrigley Keeps Kids Smiling Through Donation to American Dental Association Program 3Health News:Wrigley Keeps Kids Smiling Through Donation to American Dental Association Program 4Health News:American Chemical Society's weekly PressPac -- Jan. 23, 2008 2Health News:American Chemical Society's weekly PressPac -- Jan. 23, 2008 3Health News:American Chemical Society's weekly PressPac -- Jan. 23, 2008 4Health News:American Chemical Society's weekly PressPac -- Jan. 23, 2008 5Health News:American Chemical Society's weekly PressPac -- Jan. 23, 2008 6Health News:American Chemical Society's weekly PressPac -- Jan. 23, 2008 7Health News:American Chemical Society's weekly PressPac -- Jan. 23, 2008 8Health News:American Chemical Society's weekly PressPac -- Jan. 23, 2008 9Health News:American Chemical Society's weekly PressPac -- Jan. 23, 2008 10Health News:Caffeine Could Spell Trouble for Diabetics 2Health News:NutraCea Provides Update on Domestic Operations 2Health News:NutraCea Provides Update on Domestic Operations 3
... Dimension cardiovascular ultrasound system is the world's ... fully integrated real-time 4D and multi-dimensional imaging ... member of the Vivid 7 family, provides ... diagnosing heart conditions such as heart failure ...
... Expandable Spinal System is intended for use ... - preloaded on its Delivery System - ... in a reduced configuration of 5 mm ... 15mm (depending on the size selected) once ...
... Rhe Vivid 7 system is GEs ... new level of image quality to echocardiography, ... diagnostic confidence to clinicians.,By listening to customer ... created the first ergonomically-designed cardiovascular system that ...
... Radi invented the guidewire-mounted pressure sensor ... PressureWire5 Sensor is the only sensor ... temperature and flow. With significantly improved ... as your primary guidewire, as well ...
Medicine Products: